Philip Grant

4.4k total citations · 1 hit paper
61 papers, 2.5k citations indexed

About

Philip Grant is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Philip Grant has authored 61 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 28 papers in Virology and 16 papers in Epidemiology. Recurrent topics in Philip Grant's work include HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (28 papers) and HIV/AIDS Research and Interventions (17 papers). Philip Grant is often cited by papers focused on HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (28 papers) and HIV/AIDS Research and Interventions (17 papers). Philip Grant collaborates with scholars based in United States, Rwanda and Canada. Philip Grant's co-authors include Aruna Subramanian, Catherine A. Blish, Jonasel Roque, Arjun Rustagi, Angela J. Rogers, Thanmayi Ranganath, Laura J. Simpson, Nancy Q. Zhao, Andrew Zolopa and Giovanny J. Martínez-Colón and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and PLoS ONE.

In The Last Decade

Philip Grant

59 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

2020 915 citations Aaron J. Wilk, Arjun Rustagi et al. Nature Medicine profile →

Peers

Countries citing papers authored by Philip Grant

Since Specialization

Citations

This map shows the geographic impact of Philip Grant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Grant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Grant more than expected).

Fields of papers citing papers by Philip Grant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Grant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Grant. The network helps show where Philip Grant may publish in the future.

Co-authorship network of co-authors of Philip Grant

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Grant. A scholar is included among the top collaborators of Philip Grant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Grant. Philip Grant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Age-dependent cytokine surge in blood precedes cancer diagnosis 2025 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Hong Zheng, Yael Rosenberg‐Hasson, (unknown), Kavita Y. Sarin, Cornelia L. Dekker, Philip Grant, Holden T. Maecker, Ying Lü, David Furman, Shai S. Shen-Orr, Purvesh Khatri, Mark M. Davis	0
2	Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review 2024 ·Viruses ·Carolyn Chu, Kaiming Tao, (unknown), Ava Avalos, Jake Scott, Philip Grant, Soo‐Yon Rhee, Suzanne M. McCluskey, Michael R. Jordan, Rebecca L. Morgan, Robert W. Shafer	23
3	Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution 2024 ·Science Translational Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Philip Grant, Hector Bonilla, Marisa Holubar, Upinder Singh, Karen B. Jacobson, Prasanna Jagannathan, Yvonne Maldonado, Susan Holmes, Aruna Subramanian, Catherine A. Blish	15
4	Associations between county-level public health expenditures and community health planning activities with COVID-19 incidence and mortality 2023 ·Preventive Medicine Reports ·Richard Liang, Mathew V. Kiang, Philip Grant, Christian Jackson, David H. Rehkopf	2
5	Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic 2021 ·Clinical Infectious Diseases ·Karen B. Jacobson, (unknown), Hector Bonilla, Aruna Subramanian, (unknown), (unknown), Upinder Singh, Prasanna Jagannathan, Philip Grant	129
6	Factors Associated with Resilience Among Older People Living with HIV 2021 ·AIDS and Behavior ·(unknown), Peter Mazonson, (unknown), Philip Grant, Andrew Zolopa, (unknown), (unknown)	1
7	Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection 2020 ·AIDS ·Nitya S. Ramadoss, Nancy Q. Zhao, Barbra A. Richardson, Philip Grant, Peter S. Kim, Catherine A. Blish	17
8	A single-cell atlas of the peripheral immune response in patients with severe COVID-19 breakdown → 2020 ·Nature Medicine ·Aaron J. Wilk, Arjun Rustagi, Nancy Q. Zhao, Jonasel Roque, Giovanny J. Martínez-Colón, Julia L. McKechnie, Geoffrey T. Ivison, Thanmayi Ranganath, Rosemary Vergara, Taylor Hollis, Laura J. Simpson, Philip Grant, Aruna Subramanian, Angela J. Rogers, Catherine A. Blish	915
9	Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis 2020 ·JCI Insight ·Jennifer G. Wilson, Laura J. Simpson, Anne-Maud Ferreira, Arjun Rustagi, Jonasel Roque, (unknown), Thanmayi Ranganath, Philip Grant, Aruna Subramanian, Yael Rosenberg‐Hasson, Holden T. Maecker, Susan Holmes, Joseph E. Levitt, Catherine A. Blish, Angela J. Rogers	179
10	Effect of Testosterone Use on Bone Mineral Density in HIV-Infected Men 2018 ·AIDS Research and Human Retroviruses ·Philip Grant, Xiuhong Li, Lisa P. Jacobson, Frank J. Palella, Lawrence Kingsley, Joseph B. Margolick, Adrian S. Dobs, Jordan E. Lake, Keri N. Althoff, Todd T. Brown	6
11	A Comparison of the Liver Fat Score and CT Liver-to-Spleen Ratio as Predictors of Fatty Liver Disease by HIV Serostatus 2018 ·PubMed ·(unknown), Jordan E. Lake, Holly Wilhalme, (unknown), Philip Grant, Kristine M. Erlandson, Jennifer C. Price, Frank J. Palella, (unknown), Matthew J. Budoff, Wendy S. Post, Todd T. Brown	3
12	Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients 2015 ·AIDS Research and Human Retroviruses ·Philip Grant, Virginia Sheikh, Rebecca DerSimonian, Adam Rupert, Gregg Roby, Alice K. Pau, Michael C. Sneller, (unknown), Todd T. Brown, Irini Sereti	1
13	Evolution of HIV treatment guidelines in high- and low-income countries: Converging recommendations 2013 ·Antiviral Research ·Eugene T Richardson, Philip Grant, Andrew Zolopa	16
14	When to Start ART in the Setting of Acute AIDS-Related Opportunistic Infections: The Time Is Now! 2012 ·Current HIV/AIDS Reports ·Philip Grant, Andrew Zolopa	16
15	International Cohort Analysis of the Antiviral Activities of Zidovudine and Tenofovir in the Presence of the K65R Mutation in Reverse Transcriptase 2010 ·Antimicrobial Agents and Chemotherapy ·Philip Grant, Jonathan Taylor, Andrew Nevins, Vincent Cálvez, Anne‐Geneviève Marcelin, Marc Wirden, Andrew Zolopa	9
16	Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis 2010 ·AIDS ·Eran Bendavid, Philip Grant, (unknown), Douglas K Owens, Andrew Zolopa	35
17	Risk Factor Analyses for Immune Reconstitution Inflammatory Syndrome in a Randomized Study of Early vs. Deferred ART during an Opportunistic Infection 2010 ·PLoS ONE ·Philip Grant, Lauren Komarow, Janet Andersen, Irini Sereti, Savita Pahwa, Michael M. Lederman, Joseph J. Eron, Ian Sanne, William G. Powderly, Evelyn Hogg, (unknown), Andrew Zolopa	119
18	The use of resistance testing in the management of HIV-1-infected patients 2009 ·Current Opinion in HIV and AIDS ·Philip Grant, Andrew Zolopa	17
19	The Effect of a Multidisciplinary Program on HAART Adherence 2006 ·AIDS Patient Care and STDs ·Pamela Frick, Kenneth Tapia, Philip Grant, (unknown), (unknown)	26
20	Arteriogenic Impotence: Findings in 195 Impotent Men Examined with Selective Internal Pudendal Angiography 1990 ·Radiology ·Max P. Rosen, Alan J. Greenfield, T. Gregory Walker, Philip Grant, Jon K. Guben, (unknown), Michael A. Bettmann, Irwin Goldstein	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact